TEL AVIV, Israel I March 20, 2018 I Therapix Biosciences Ltd. (NASDAQ: TRPX) (“Therapix” or the “Company”), a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today that the U.S. … Read More
The post Therapix Biosciences Announces FDA Clearance of Investigational New Drug (IND) for Phase IIa … appeared first on Dagga Magazine.